MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
Mater Hospital
Belfast, Reino UnidoPublicaciones en colaboración con investigadores/as de Mater Hospital (3)
2016
-
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy
European Journal of Cancer, Vol. 56, pp. 85-92
2015
-
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy
Breast Cancer Research, Vol. 17, Núm. 1
2013
-
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial
The Lancet Oncology, Vol. 14, Núm. 1, pp. 88-96